Clear history
Screening
Clear history
  • The Efficacy of Early Additional Hemoperfusion Therapy for Severe COVID-19 Patients: A Prospective Cohort Study.

    Surasit, K., & Srisawat, N. (2022). Blood Purification, 1-10.

  • Can the Reduction of Cytokines Stop the Progression of Sepsis?

    Koc, S., Celebi, S., Hanikoglu, F., Polat, Y., Uysal, B. B., Dokur, M., ... & Kupeli, İ. (2022). Cureus, 14(2).

  • Additional hemoperfusion is associated with improved overall survival and self-reported sleep disturbance in patients on hemodialysis.

    Gu, Y. H., Yang, X. H., Pan, L. H., Zhan, X. L., Guo, L. L., & Jin, H. M. (2019). The International Journal of Artificial Organs, 42(7), 347-353

  • Acute abrin poisoning treated with continuous renal replacement therapy and hemoperfusion successfully

    Huang, J., Zhang, W., Li, X., Feng, S., Ye, G., Wei, H., & Gong, X. (2017).Medicine, 96(27).

  • POS-854 NEGATIVE ALACTIC VALUE IS REVERSED BY HEMOPERFUSION IN SEPTIC PATIENTS

    Guido, C. M., Pablo, J. C., Martinez, G. A., et al. Kidney International Reports, 2022, 7(2), S369.

  • POS-568 CLINICAL OBSERVATION OF FRACTIONATED PLASMA SEPARATION AND ADSORPTION MODE INTEGRATED WITH CONTINUOUS VENO-VENOUS HAEMOFILTRATION APPLIED IN THE TREATMENT OF PATIENTS WITH SEVERE POISONING

    DONG J, Li C, Huang L, Wu B, Fan W, Huang L, Ge Y. Kidney International Reports (2022) 7, S1–S436.

  • POS-855 MORTALITY RATE AND ACUTE KIDNEY INJURY PREVALENCE REDUCTION IN COVID-19 CRITICAL PATIENTS TREATED WITH HEMOPERFUSION

    Lozano-Sanchez M, Pablo J C, Aroca-Martinez G, et al. Kidney International Reports, 2022, 7(2): S369.

  • The Clinical Efficacy of Double Plasma Molecular Absorption System Combined with Plasma Exchange in the Treatment of Acute-on-Chronic Liver Failure: A Systematic Review and Meta-Analysis

    Bai W, Yao C, Mao D, Wu J, Wang K, Wei H, Huang Z, Shi Q, Wang N. J Healthc Eng. 2022 Mar 25;2022:3139929.

  • Bilirubin adsorption for the treatment of severe hyperbilirubinemia after cardiac surgery: A retrospective cohort study

    Chen X, Li L, Bai M, Sun S, Chen X. Int J Artif Organs. 2022 Feb;45(2):146-151.

  • POS-875 THE CLINICAL PROFILE AND OUTCOME OF PATIENTS WITH COVID 19 WHO UNDERWENT HEMOPERFUSION IN BATAAN GENERAL HOSPITAL AND MEDICAL CENTER

    Siasat A, Ilagan B C, Reyes A, et al. Kidney International Reports, 2022, 7(2): S378-S379.

  • Meta-Analysis of the efficacy of DPMAS-based articial liver in the treatment of ACLF

    L Ma, X Zhang, W Ma, X Ding.2022.researchsquare.com

  • The efficacy of resin hemoperfusion cartridge on inflammatory responses during adult cardiopulmonary bypass.

    He, Z., Lu, H., Jian, X., Li, G., Xiao, D., Meng, Q., ... & Zhou, C. (2022). Blood Purification, 51(1), 31-37.

  • An incident of chloroform poisoning on a university campus

    Cui, Si-Qi et al. World journal of emergency medicine vol. 13,2 (2022): 155-157.

  • SUCCESSFUL TREATMENT OF AN END-STAGE KIDNEY DISEASE PATIENT PRESENTING WITH SEVERE COVID-19 DISEASE USING ENHANCED CYTOKINE REMOVAL WITH HAEMOADSORPTION THERAPY IN ADDITION TO STANDARD MANAGEMENT

    Tan, E. Z. Z., & Wong, H. S. (2022). Journal of Clinical and Translational Nephrology, 1.

  • COMBINED EXTRACORPOREAL BLOOD PURIFICATION IN A PATIENT WITH SEVERE COVID-19 AND SEPTIC SHOCK

    Avetisyan EA, Merkulova IA, Pevsner DV, Pokrovskiy SN.38th Vicenza Course on AKI&CRRT

  • HEMOPERFUSION IN ERC5D PATIENT WITH SEPSIS PICTURE DUE TO ACUTE INTERSTITIAL PNEUMONIA SECONDARY TO SARS COV 2 (COVID 19) INFECTION

    Salomé, Jorge, Panta, Marilyn, Duque. Jessica, Médico Nefrólogo, Specialist nurses

  • COMPARISON OF DEATH ODDS RATIO IN PATIENTS WITH COVID-19 IN GROUPS WITH CONSERVATIVE THERAPY AND AFTER CYTOKINE ADSORPTION

    Nogaibayeva A., Zhunussov A., Ivanov Y., Kanafina Sh., Vakhrushev I. Jabayeva N., Udalova A. 38th Vicenza Course on AKI&CRRT

  • EFFECT OF EXTRACORPOREAL HEMOPERFUSION REMOVAL OF INFLAMMATORY MEDIATORS AND SURVIVAL IN END STAGE LIVER DISEASE PATIENTS WITH SEPTIC SHOCK

    Dinesh Devarajan, Akila Rajakumar, Dinesh Jothimani, Jagdish K. 38th Vicenza Course on AKI&CRRT

  • ECBP IN CRITICALLY ILL SEPTIC PATIENTS

    E. Chrysanthopoulou, A. Armaganidis. 38th Vicenza Course on AKI&CRRT

  • THERAPEUTICAL APPROACH OF HA330 ABSORBER IN CASE OF SEPSIS IN CHILDREN

    Askhat Saparov, Zaure Tobylbayeva, Ramazan Abylkassov, Samat Issakov, Vitaliy Sazonov. 38th Vicenza Course on AKI&CRRT